Study of Two Doses of GSK Biologicals' Live Attenuated HRV Vaccine (Two Different Formulations) in Healthy Infants.

Clinical trial NCT00729001 · COMPLETED

Trial details

NCT number: NCT00729001
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Infections, Rotavirus

Start date: 2000-11-01
Primary completion: 2002-09-01
Enrollment: 529

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.